Search hospitals > District of Columbia > Washington

MedStar Washington Hospital Center

Claim this profile
Washington, District of Columbia 20010
Global Leader in Breast Cancer
Global Leader in Parotid Gland Cancer
Conducts research for Coronary Artery Disease
Conducts research for Heart Failure
Conducts research for Stroke
626 reported clinical trials
75 medical researchers
Photo of MedStar Washington Hospital Center in WashingtonPhoto of MedStar Washington Hospital Center in WashingtonPhoto of MedStar Washington Hospital Center in Washington

Summary

MedStar Washington Hospital Center is a medical facility located in Washington, District of Columbia. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Coronary Artery Disease, Heart Failure, Stroke and other specialties. MedStar Washington Hospital Center is involved with conducting 626 clinical trials across 749 conditions. There are 75 research doctors associated with this hospital, such as Ron Waksman, M.D., Anteneh A. Tesfaye, Benjamin A. Weinberg, and Stephen V. Liu.

Area of expertise

1Breast Cancer
Global Leader
MedStar Washington Hospital Center has run 58 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
PR positive
2Parotid Gland Cancer
Global Leader
MedStar Washington Hospital Center has run 50 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
HER2 positive

Top PIs

Clinical Trials running at MedStar Washington Hospital Center

Bladder Cancer
Lung Cancer
Breast Cancer
Parotid Gland Cancer
Kidney Cancer
Prostate Cancer
Atrial Fibrillation
Pancreatic Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Image of trial facility.

Cretostimogene Grenadenorepvec

for Bladder Cancer

This is a Phase 3, open-label, randomized trial designed to evaluate the RFS of TURBT followed by cretostimogene grenadenorepvec versus TURBT followed by surveillance for the treatment of participants with IR-NMIBC.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

Gemcitabine + Docetaxel vs BCG

for Bladder Cancer

This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.
Recruiting2 awards Phase 314 criteria
Image of trial facility.

Disitamab Vedotin + Pembrolizumab

for Bladder Cancer

This trial is testing a new drug called disitamab vedotin, alone or with pembrolizumab, for patients with advanced or metastatic HER2 expressing bladder cancer. Disitamab vedotin is designed to target HER2 and has been approved for other types of cancer. The study aims to see if these drugs can effectively treat the cancer and what side effects they might cause.
Recruiting1 award Phase 24 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at MedStar Washington Hospital Center?
Where is MedStar Washington Hospital Center located?
Who should I call to ask about financial aid or insurance network?
What insurance does MedStar Washington Hospital Center accept?
What awards or recognition has MedStar Washington Hospital Center received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security